Dice Medical Communications
- Agency description
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Pharmacohesion™ helps brands thrive by continually shaping and adapting the conversation with all stakeholders, in a consistent, cohesive way.
Brands nurtured with Pharmacohesion™ thrive because:
- customers, whether they are prescribers, payors, carers or patients, know exactly what to expect from your brand in terms of how it impacts on their lives
- your brand communication is always in tune with therapeutic sentiment which also helps to withstand competitive challenges
We create Pharmacohesion™ by bringing together insights, strategy, execution, and measurement to your brands.
- We use our network to uncover your customers’ mindsets, generating INSIGHTS that matter
- We integrate these insights into your plans – defining and refining STRATEGY based on our in-depth understanding of the market situation
- We deliver impactful, strategically-aligned tactical initiatives across all channels: EXECUTION that captures your brand values in a context that is meaningful for all your customers
- Our continued rigorous analysis helps MEASURE success and further refine customer insights, delivering ROI.
Together, it is truly transformational. Get in touch to discuss how we can create Pharmacohesion™ for your brands.
- Key contact
- Matthew Dickinson
- Managing Director
- 01628 397 830
- 2019 Agency Data
- This information was supplied or confirmed by Dice Medical Communications. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
Subscribe to our email news alerts
- The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
- By Leela Barham...
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Roche reports continued growth in Q3, despite biosimilar competition
- Roche eyes filings for Tecentriq/Avastin combo in liver cancer
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Janssen files Tremfya for psoriatic arthritis in Europe
- UK rations AZ’s paediatric flu vaccine after delivery delays
- Biogen and Eisai revive abandoned aducanumab in shock turnaround
- Millennial Physicians And Digital Health Services
- Pharma Brand Planners' Blog (Part 5)
- Tapping the potential of rare diseases: A journey into uncharted territory